Quest Diagnostics (DGX)
(Real Time Quote from BATS)
$152.77 USD
-1.21 (-0.79%)
Updated Sep 24, 2024 02:46 PM ET
2-Buy of 5 2
B Value C Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DGX 152.77 -1.21(-0.79%)
Will DGX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DGX
ITGR Shares May Gain on the Completion of Irish Facility Expansions
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
DGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Stryker Shares May Gain on the Completion of the Acquisition of NICO
SNN Stock Rises on the Completion of First Case With CATALYSTEM System
Other News for DGX
Stocks that are expected to benefit from lower fed funds rate and a softer labor market
American Century Mid Cap Value Fund Q2 2024 Commentary
Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast
Quest Diagnostics and Sentara Health Plans announce collaboration
Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health